I saw this on SEC website ….
$T2 Biosystems(TTOO.US$ of Listing.
On November 5, 2021, the Company received a letter (the "Nasdaq Staff Deficiency Letter")
from The Nasdaq Stock Market LLC ("Nasdaq") indicating that, for the last thirty consecutive
business days, the bid price for the Company's common stock had closed below the minimum
$1.00 per share requirement for continued listing on The Nasdaq Global Market under Nasdaq
Listing Rule 5450(a) (1).
In accordance with Nasdaq Listing Rule 5810(c)(3)(A)i), the Company has been provided
an initial period of 180 calendar days, or until May 4, 2022, to regain compliance. The letter
states that the Nasdaq staff will provide written notification that the Company has achieved
compliance with Rule 5450(a)(1) if at any time before May 4, 2022, the bid price of the
Company's common stock closes at $1.00 per share or more for a minimum of ten consecutive
business days. The Nasdaq Staff Deficiency Letter has no immediate effect on the listing or
trading of the Company's common stock.
The Company intends to monitor the bid price of its common stock and consider available
options, including effecting a reverse stock split, if its common stock does not trade at a level
likely to result in the Company regaining compliance with Nasdaq's minimum bid price rule by
May 4, 2022.
If the Company does not regain compliance with Rule 5450(a) (1) by May 4, 2022, the
Company may transfer to The Nasdaq Capital Market, provided that it meets the continued
listing requirement for the market value of publicly held shares and all other initial listing
standards for The Nasdaq Capital Market, except for the minimum bid price rule, and the
Company would need to provide written notice to Nasdaq of its intention to cure the deficiency
during the additional compliance period. Following a transfer to The Nasdaq Capital Market,
under Nasdaq Listing Rule 5810(c)(3)(A)(ii), the Company may be eligible for an additional 180
calendar day compliance period.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant
On November 5, 2021, the Company received a letter (the "Nasdaq Staff Deficiency Letter")
from The Nasdaq Stock Market LLC ("Nasdaq") indicating that, for the last thirty consecutive
business days, the bid price for the Company's common stock had closed below the minimum
$1.00 per share requirement for continued listing on The Nasdaq Global Market under Nasdaq
Listing Rule 5450(a) (1).
In accordance with Nasdaq Listing Rule 5810(c)(3)(A)i), the Company has been provided
an initial period of 180 calendar days, or until May 4, 2022, to regain compliance. The letter
states that the Nasdaq staff will provide written notification that the Company has achieved
compliance with Rule 5450(a)(1) if at any time before May 4, 2022, the bid price of the
Company's common stock closes at $1.00 per share or more for a minimum of ten consecutive
business days. The Nasdaq Staff Deficiency Letter has no immediate effect on the listing or
trading of the Company's common stock.
The Company intends to monitor the bid price of its common stock and consider available
options, including effecting a reverse stock split, if its common stock does not trade at a level
likely to result in the Company regaining compliance with Nasdaq's minimum bid price rule by
May 4, 2022.
If the Company does not regain compliance with Rule 5450(a) (1) by May 4, 2022, the
Company may transfer to The Nasdaq Capital Market, provided that it meets the continued
listing requirement for the market value of publicly held shares and all other initial listing
standards for The Nasdaq Capital Market, except for the minimum bid price rule, and the
Company would need to provide written notice to Nasdaq of its intention to cure the deficiency
during the additional compliance period. Following a transfer to The Nasdaq Capital Market,
under Nasdaq Listing Rule 5810(c)(3)(A)(ii), the Company may be eligible for an additional 180
calendar day compliance period.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Fly5959OP : @Tupack H Mcsnacks
Hope to hear your opinion on this counter when you are free. Thank you
Mcsnacks H Tupack Fly5959OP: They will reverse split. $Stran & Company (STRN.US)$ look into it. You will be glad you did.
想发财的疯子 : what does it mean?
Mcsnacks H Tupack : I Finally Figured out tHeir new algorithm they are using. I’m Going to take their money starting Monday. Lots of it.
Fly5959OP Mcsnacks H Tupack: Take from TTOO?
Mcsnacks H Tupack Fly5959OP: Ttoo will have an ok monday but Tuesday will be it’s best day. But I can use it on any stock. CCXI is going to gap up Monday to 48.00. And shorts are going to finally cover and send it up to 71.00 on Tuesday.
Fly5959OP Mcsnacks H Tupack: My current average cost is about $1. Should I average down and wait a while more or I should just dump & pump into CCXI, STRN, etc?
msudac Mcsnacks H Tupack: Is that what this order is? Shorts covering?
Daniel Zn Mcsnacks H Tupack: Option contracts haven’t expired yet Tupack. Wouldn’t ccxi be stuck at 39 with those calls
Mcsnacks H Tupack Daniel Zn: That’s what’s going to pull them up to 48.00 when the calls Get exercised Monday. It has a 3.00 move up coming on Monday no matter what. Shares are already sold. Then the short sellers who have been holding since July are going to give in and start covering in premarket Monday or premarket Tuesday.
View more comments...